Trump Administration
Refine search
Pharmaceutical
In July 2025 the White House sent letters to 17 large drugmakers asking them to match, for American patients, the lowest prices they charge in other wealthy nations. A year on, all 17 have signed "most-favored-nation" (MFN) pricing deals. The administration says the group accounts for about 86% of the branded US market. 4 August 2026
Pharmaceutical
The USA is preparing to release $600 million in congressional funding for Gavi, the Vaccine Alliance, ending months of uncertainty over Washington's support for the global immunization body. The money, appropriated for the 2025 and 2026 fiscal years, had been held back amid a dispute over vaccine safety and how the alliance chooses and buys its shots. 30 July 2026
Pharmaceutical
Trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has cited new polling in a renewed attack on US government drug price controls, arguing that voters are more concerned about health insurers and pharmacy benefit managers (PBMs) than proposals to expand 'Most Favored Nation' (MFN) pricing. 27 July 2026
Generics
US president Donald Trump has set a countdown for tariffs on imported generic medicines, ending an exemption that had shielded the copycat drugs supplying the bulk of US prescriptions. Announcing the plan on his Truth Social platform, he framed the levies as a penalty for companies that decline to shift production onto American soil. 23 July 2026
Generics
Indian pharmaceutical stocks fell sharply on July 22 after US President Donald Trump announced plans to impose steep tariffs on imported generic drugs beginning in 2028. 22 July 2026
Biosimilars
US lawmakers have introduced bipartisan legislation that would reduce routine reliance on comparative clinical efficacy studies in biosimilar approvals, a move welcomed by the Association for Accessible Medicines (AAM) and its Biosimilars Council. 16 July 2026
Biotechnology
The US Department of Health and Human Services has launched a department-wide clinical trials reform initiative aimed at accelerating drug development, reducing unnecessary regulatory burden and reinforcing the USA’s position in global biomedical research. 23 June 2026
Pharmaceutical
The US Trade Representative (USTR) has launched a Section 301 investigation into Germany’s pharmaceutical pricing policies, escalating a dispute over how the costs of innovative medicines are shared between the USA and other wealthy markets. 22 June 2026
Biotechnology
Chinese life sciences services group WuXi AppTec has sued the US government over its inclusion on a Pentagon list of companies alleged to have links to China’s military, escalating a dispute with potentially wide implications for pharma outsourcing. 22 June 2026
Pharmaceutical
Jeffery Taubenberger, the acting director of the US National Institute of Allergy and Infectious Diseases (NIAID), has stepped down from the role, according to reports citing congressional Democrats and sources familiar with the matter. 22 May 2026
Pharmaceutical
New US tariff measures and acute geopolitical tensions are reshaping the global pharmaceutical landscape, prompting companies to rethink supply chains and production strategies, says intelligence and productivity platform. GlobalData. 8 May 2026
Pharmaceutical
US President Donald Trump on April 18 issued an Executive Order directing the US Department of Health and Human Services to accelerate access to treatments for patients with serious mental illness, including devastating, complex, and treatment-resistant conditions. 25 April 2026
Pharmaceutical
US President Donald Trump has nominated Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC) after a long search for a replacement for Susan Monarez, who was sacked in August last year. 17 April 2026
Pharmaceutical
The number of drug launches in Europe has fallen by around 35% in the 10 months since the USA introduced a new drug pricing policy, according to an analysis by the international research agency GlobalData. The figures are serious for European patients, says the Danish pharma trade group Lif. 13 April 2026
Pharmaceutical
Pharma trade group Medicines Australia says that, along with its members, it supports free, fair, and open trade and firmly oppose the proposed introduction of 100% tariffs on Australian branded and patented medicines exported to the USA. 10 April 2026
Pharmaceutical
Stephen Ubl will step down as president and chief executive of the Pharmaceutical Research and Manufacturers of America (PhRMA) at the end of 2026, ending a decade leading one of Washington’s most influential drug industry groups. 9 April 2026
Pharmaceutical
US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) appears to have found a means of selecting members himself for a Centers for Disease Control and Prevention (CDC) vaccine advisory panel. 7 April 2026
Generics
In a dramatic move, the USA has announced a 100% tariff on all patented pharmaceutical imports, a decision aimed at bolstering domestic drug manufacturing and reducing reliance on foreign producers. 3 April 2026
Pharmaceutical
Nearly 8,000 clinical trial sites have been disrupted by the USA's escalating war on Iran, according to new analysis from clinical data firm Phesi, highlighting the fragility of globally distributed drug development. 2 April 2026
Pharmaceutical
US physician and biochemist Robert Malone has stepped down from the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices, after a federal court ruling derailed a contentious revamp of the panel. 30 March 2026
Pharmaceutical
Reducing patient healthcare costs is imperative, write Matthew Majewski and Andrew Parece, vice presidents of Charles River Associates, in a Special Report. 21 October 2020
Biotechnology
As US President Donald Trump puts his weight behind Eli Lilly and Regeneron Pharmaceuticals’ bid for US Food and Drug Administration Emergency Use Authorization (EUA) for their respective COVID-19 monoclonal antibody (MAb) therapies, pharma writers for the investigative team at GlobalData assess the situation. 12 October 2020
Pharmaceutical
On Tuesday, the US Food and Drug Administration issued guidance with recommendations for vaccine sponsors regarding the scientific data and information that would support the issuance of an emergency use authorization (EUA) for an investigational vaccine intended to prevent COVID-19. 7 October 2020
Pharmaceutical
US President Donald Trump several weeks ago threatened drug manufacturers with the prospect of an Executive Order mandating international reference price limitations, unless the manufacturers put forward proposals to significantly reduce drug prices by August 24. 15 September 2020
Pharmaceutical
The US Food and Drug Administration on Sunday issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency’s ongoing efforts to fight COVID-19. 24 August 2020
Generics
US President Donald Trump on Thursday signed an Executive Order to increase American production of essential medical supplies and cut down the nation’s reliance on foreign producers of medicines. 7 August 2020
Pharmaceutical
US pharma trade group Pharmaceutical Research and Manufacturers of America (PhRMA) has responded to a report on drug pricing from industry analyst IQVIA. 7 August 2020
Generics
What was once a leading photography company, but which filed for bankruptcy protection in 2012, USA-based Eastman Kodak’s shares soared as much as 1,900% in two days, after the Wall Street Journal reported the company had won a $765M government loan under the Defense Production Act. 29 July 2020
Pharmaceutical
Early in the current White House administration, exceptionally strong rhetoric around drug pricing from US President Donald Trump rattled pharma markets, as investors feared new measures to control drug prices were imminent. 27 July 2020
Pharmaceutical
The right-wing Institute for Policy Innovation has criticized a reported proposal from US President Donald Trump to introduce international price benchmarking, part of a plan to control drug prices in the country. 24 July 2020
Biotechnology
As Gilead Sciences revealed the price of remdesivir, its potential antiviral treatment for COVID-19, the US government announced that it has got its hands on another huge batch of the drug. 30 June 2020
Biotechnology
Shares in US biotech Vaxart were gaining further on Monday following Friday’s 28% leap. 29 June 2020
Pharmaceutical
The US National Institutes of Health (NIH) and Swiss pharma giant Novartis have both stopped trials of hydroxychloroquine in COVID-19. 22 June 2020
Pharmaceutical
A legal challenge from healthcare professionals in the USA will seek to end “arbitrary interference” from the US regulator over the use of hydroxychloroquine (HCQ). 3 June 2020
Generics
The US government has awarded $354 million to a start-up, Phlow Corporation, to boost local production of drugs at risk of shortage, including medicines to treat COVID-19. 20 May 2020
Pharmaceutical
On Friday, US President Donald Trump announced the addition of two of the most highly respected and skilled professionals to the White House new initiative, dubbed Operation Warp Speed, the objective of which is to finish developing and then to manufacture and distribute a proven coronavirus vaccine as fast as possible. 16 May 2020
Pharmaceutical
The US House of Representatives and Senate on Wednesday and Thursday passed an $8.3 billion emergency funding package, which dwarfs the $2.5 billion request by the White House, and it was signed off by President Donald Trump on Friday morning. 6 March 2020
Pharmaceutical
Where previous exchanges with big pharma bosses have generally seen US President Donald Trump attempt to exert pressure on companies on pricing, Tuesday’s meeting saw him adopting a different tone. 4 March 2020
Pharmaceutical
As the Office of the US Trade Representative (USTR) prepares its annual “Special 301 Report,” the US pharmaceutical industry has submitted comments calling for an end to market access barriers globally. 10 February 2020
Pharmaceutical
In US President Donald Trump’s State of the Union address on Tuesday, he again called for further bipartisan legislation to lower drug prices. 5 February 2020
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze